Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11840536 Heterocyclic inhibitors of PTPN11

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jason Cross0

Barbara Czako0

Philip Jones0

Connor Parker0

Paul Leonard0

Faika Mseeh0

Date of Patent

December 12, 2023

0

Patent Application Number

178769580

Date Filed

July 29, 2022

0

Patent Citations

US Patent 10280171 Heterocyclic inhibitors of PTPN11

0

US Patent 10954243 Substituted heterocyclic inhibitors of PTPN11

0

US Patent 10851110 Heterocyclic inhibitors of PTPN11

0

US Patent 11104675 PTPN11 inhibitors

0

US Patent 7897607 Cyclic compounds

0

US Patent 9522881 Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)

0

Patent Primary Examiner

Samantha L Shterengarts

0

Patent abstract

The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11840536 Heterocyclic inhibitors of PTPN11

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool